Raymond James & Associates’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,345
Closed -$178K 4041
2024
Q1
$178K Buy
+12,345
New +$178K ﹤0.01% 3614